• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮-间质转化在肝癌细胞对奥沙利铂的耐药性中起关键作用。

Epithelial-mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatin.

作者信息

Ma Jun Li, Zeng Shan, Zhang Yan, Deng Gan Lu, Shen Hong

机构信息

Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China, 410008.

出版信息

Tumour Biol. 2016 May;37(5):6177-84. doi: 10.1007/s13277-015-4458-z. Epub 2015 Nov 27.

DOI:10.1007/s13277-015-4458-z
PMID:26614432
Abstract

Drug resistance is one characteristic of hepatocellular carcinoma (HCC) and can affect the prognosis of patients directly. To explore drug resistance well, we established an oxaliplatin (OXA)-resistant cell line Bel-7402/OXA by exposure to gradually increased concentration of OXA. Some biological characters, such as proliferation, migration, and invasion, were studied. Drug sensitivity and the mechanisms of drug resistance were also investigated. We found that the resistant index of Bel-7402/OXA was 8.3. In comparison with Bel-7402, the percentages of cells in S and G2/M phase were increased. The nature apoptosis rate and drug-after apoptosis rate were all decreased in Bel-7402/OXA, as compared to Bel-7402. Bel-7402/OXA acquired increased migration and invasion ability with epithelial-mesenchymal transition (EMT) phenotype. Knockdown of EMT transcription factor Snail could reverse EMT and sensitized Bel-7402/OXA cells to OXA. EMT was one mechanism of drug resistance and may be a novel target of treatment for drug resistance.

摘要

耐药性是肝细胞癌(HCC)的一个特征,可直接影响患者的预后。为了深入探究耐药性,我们通过逐步增加奥沙利铂(OXA)的浓度,建立了奥沙利铂耐药细胞系Bel-7402/OXA。研究了其一些生物学特性,如增殖、迁移和侵袭。还研究了药物敏感性和耐药机制。我们发现Bel-7402/OXA的耐药指数为8.3。与Bel-7402相比,S期和G2/M期细胞的百分比增加。与Bel-7402相比,Bel-7402/OXA的自然凋亡率和药物诱导后的凋亡率均降低。Bel-7402/OXA获得了增强的迁移和侵袭能力,并具有上皮-间质转化(EMT)表型。敲低EMT转录因子Snail可逆转EMT,并使Bel-7402/OXA细胞对OXA敏感。EMT是耐药的一种机制,可能是耐药治疗的一个新靶点。

相似文献

1
Epithelial-mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatin.上皮-间质转化在肝癌细胞对奥沙利铂的耐药性中起关键作用。
Tumour Biol. 2016 May;37(5):6177-84. doi: 10.1007/s13277-015-4458-z. Epub 2015 Nov 27.
2
The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.荷叶碱通过 EMT 调控 Snail 信号通路对肝癌细胞侵袭和奥沙利铂敏感性的抗肿瘤活性。
Sci Rep. 2017 Jan 30;7:41616. doi: 10.1038/srep41616.
3
BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma.BMP4 通过 MEK1/ERK/ELK1 信号通路诱导上皮-间充质转化促进肝癌对奥沙利铂耐药。
Cancer Lett. 2017 Dec 28;411:117-129. doi: 10.1016/j.canlet.2017.09.041. Epub 2017 Oct 4.
4
Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.长链非编码 RNA AK021443 通过调控肝癌细胞上皮-间充质转化促进细胞增殖和迁移。
DNA Cell Biol. 2018 May;37(5):481-490. doi: 10.1089/dna.2017.4030. Epub 2018 Mar 14.
5
ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.ID1 通过激活戊糖磷酸途径促进肝癌细胞增殖并赋予奥沙利铂耐药性。
J Exp Clin Cancer Res. 2017 Nov 23;36(1):166. doi: 10.1186/s13046-017-0637-7.
6
Nutlin-3 reverses the epithelial-mesenchymal transition in gemcitabine-resistant hepatocellular carcinoma cells.Nutlin-3可逆转吉西他滨耐药的肝癌细胞中的上皮-间质转化。
Oncol Rep. 2016 Sep;36(3):1325-32. doi: 10.3892/or.2016.4920. Epub 2016 Jul 8.
7
Comparison of the multi-drug resistant human hepatocellular carcinoma cell line Bel-7402/ADM model established by three methods.三种方法建立的多药耐药人肝癌细胞株 Bel-7402/ADM 模型的比较。
J Exp Clin Cancer Res. 2010 Aug 20;29(1):115. doi: 10.1186/1756-9966-29-115.
8
HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.HOXB7通过促进干性和上皮-间质转化加速肝细胞癌的恶性进展。
J Exp Clin Cancer Res. 2017 Jun 24;36(1):86. doi: 10.1186/s13046-017-0559-4.
9
[Changes of metastatic potential of residual hepatocellular carcinoma in nude mice after in vivo chemotherapy and the corresponding mechanisms].[体内化疗后裸鼠残余肝细胞癌转移潜能的变化及相关机制]
Zhonghua Zhong Liu Za Zhi. 2012 Nov;34(11):805-9. doi: 10.3760/cma.j.issn.0253-3766.2012.11.002.
10
MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.MEL-pep,一种蜂毒素类似物,可破坏细胞膜并逆转人肝癌细胞对 5-氟尿嘧啶的耐药性。
Int J Biochem Cell Biol. 2018 Aug;101:39-48. doi: 10.1016/j.biocel.2018.05.013. Epub 2018 May 22.

引用本文的文献

1
Hepatocellular carcinoma drug resistance models.肝细胞癌耐药模型
Cancer Cell Int. 2025 May 28;25(1):195. doi: 10.1186/s12935-025-03821-y.
2
Mechanisms of drug resistance in hepatocellular carcinoma.肝细胞癌中的耐药机制。
Biol Proced Online. 2025 May 28;27(1):19. doi: 10.1186/s12575-025-00281-6.
3
A study on metabolic characteristics and metabolic markers of gastrointestinal tumors.胃肠道肿瘤的代谢特征及代谢标志物研究。

本文引用的文献

1
Epithelial-mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells.上皮-间质转化赋予SNU-16胃癌细胞对选择性FGFR抑制剂的抗性。
Gastric Cancer. 2016 Jan;19(1):53-62. doi: 10.1007/s10120-014-0444-1. Epub 2014 Nov 19.
2
Role of gap junction intercellular communication in testicular leydig cell apoptosis induced by oxaliplatin via the mitochondrial pathway.间隙连接细胞间通讯在奥沙利铂通过线粒体途径诱导睾丸间质细胞凋亡中的作用
Oncol Rep. 2015 Jan;33(1):207-14. doi: 10.3892/or.2014.3571. Epub 2014 Oct 29.
3
Epithelial-mesenchymal transition and drug resistance: role, molecular mechanisms, and therapeutic strategies.
Cancer Biol Ther. 2023 Dec 31;24(1):2255369. doi: 10.1080/15384047.2023.2255369.
4
Differential Splicing of Skipped Exons Predicts Drug Response in Cancer Cell Lines.外显子跳跃的差异剪接可预测癌细胞系对药物的反应。
Genomics Proteomics Bioinformatics. 2021 Dec;19(6):901-912. doi: 10.1016/j.gpb.2019.08.003. Epub 2021 Mar 2.
5
Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma.RBM8A介导的肝癌奥沙利铂耐药调控机制及分子网络
Front Oncol. 2021 Jan 22;10:585452. doi: 10.3389/fonc.2020.585452. eCollection 2020.
6
IL‑6 plays a crucial role in epithelial‑mesenchymal transition and pro‑metastasis induced by sorafenib in liver cancer.IL-6 在索拉非尼诱导的肝癌上皮间质转化和促进转移中发挥关键作用。
Oncol Rep. 2021 Mar;45(3):1105-1117. doi: 10.3892/or.2021.7926. Epub 2021 Jan 7.
7
Reelin Promotes Cisplatin Resistance by Induction of Epithelial-Mesenchymal Transition via p38/GSK3β/Snail Signaling in Non-Small Cell Lung Cancer.Reelin 通过激活 p38/GSK3β/Snail 信号通路诱导非小细胞肺癌上皮间质转化促进顺铂耐药。
Med Sci Monit. 2020 Aug 7;26:e925298. doi: 10.12659/MSM.925298.
8
Piperine Inhibits TGF-β Signaling Pathways and Disrupts EMT-Related Events in Human Lung Adenocarcinoma Cells.胡椒碱抑制人肺腺癌细胞中的TGF-β信号通路并破坏与上皮-间质转化相关的事件。
Medicines (Basel). 2020 Apr 8;7(4):19. doi: 10.3390/medicines7040019.
9
Oxymatrine reverses 5-fluorouracil resistance by inhibition of colon cancer cell epithelial-mesenchymal transition and NF-κB signaling .氧化苦参碱通过抑制结肠癌细胞上皮-间质转化和NF-κB信号通路逆转5-氟尿嘧啶耐药性。
Oncol Lett. 2020 Jan;19(1):519-526. doi: 10.3892/ol.2019.11090. Epub 2019 Nov 13.
10
Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1.新型化合物蛇床酮通过PBLD和Ras/Rap1抑制肝细胞癌进展。
Exp Ther Med. 2019 Dec;18(6):4209-4220. doi: 10.3892/etm.2019.8080. Epub 2019 Oct 7.
上皮-间充质转化与药物耐药性:作用、分子机制与治疗策略。
Oncol Res Treat. 2014;37(10):584-9. doi: 10.1159/000367802. Epub 2014 Sep 16.
4
Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study.FOLFOX4方案与阿霉素治疗中国晚期肝细胞癌患者的疗效和安全性:EACH研究的亚组分析
Oncologist. 2014 Nov;19(11):1169-78. doi: 10.1634/theoncologist.2014-0190. Epub 2014 Sep 15.
5
Oxaliplatin-based chemotherapy: a new option in advanced hepatocellular carcinoma. a systematic review and pooled analysis.基于奥沙利铂的化疗:晚期肝细胞癌的一种新选择。一项系统评价与汇总分析。
Clin Oncol (R Coll Radiol). 2014 Aug;26(8):488-96. doi: 10.1016/j.clon.2014.04.031. Epub 2014 May 21.
6
FOLFOX-4 vs. doxorubicin for hepatocellular carcinoma: could a negative result be accepted as positive?
J Hepatol. 2014 Jul;61(1):164-5. doi: 10.1016/j.jhep.2014.03.024. Epub 2014 Mar 27.
7
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
8
Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway.通过 AKT/β-连环蛋白/Snail 信号通路在顺铂耐药肺癌细胞中获得上皮-间充质转化表型和癌症干细胞样特性。
Eur J Pharmacol. 2014 Jan 15;723:156-66. doi: 10.1016/j.ejphar.2013.12.004. Epub 2013 Dec 12.
9
The Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistance.索拉非尼耐药的肝细胞癌 (HCC) 细胞增强的转移潜能。
PLoS One. 2013 Nov 11;8(11):e78675. doi: 10.1371/journal.pone.0078675. eCollection 2013.
10
Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia.亚洲晚期肝细胞癌患者奥沙利铂联合氟尿嘧啶/亚叶酸与多柔比星姑息化疗的随机、多中心、开放标签研究。
J Clin Oncol. 2013 Oct 1;31(28):3501-8. doi: 10.1200/JCO.2012.44.5643. Epub 2013 Aug 26.